DOI: 10.1055/s-00000020

Geburtshilfe und Frauenheilkunde

References

Bang YJ, Giaccone G, Im SA. et al.
First-in-human phase 1 study of margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody, in patients with HER2-positive advanced solid tumors.

Ann Oncol 2017;
28: 855-861

Download Bibliographical Data

Access:
Access: